Aerobic training in persons who have recovered from juvenile dermatomyositis

Neuromuscular Disorders

Volumn 23, Issue 12, 2013, Pages 962-968

  Riisager, M ^a   Mathiesen, P R ^b   Vissing, J ^a   Preisler, N ^a   Orngreen M C ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HOLBÆK HOSPITAL   (Denmark)

Author keywords

Aerobic training; Creatine kinase; Cycling; Fitness; Juvenile dermatomyositis; Maximal oxidative capacity

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATINE KINASE; CYCLOSPORIN; METHOTREXATE; OXYGEN;

ADOLESCENT; ADULT; AEROBIC CAPACITY; AEROBIC EXERCISE; AGE; ARTICLE; BICYCLE ERGOMETRY; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE ACTIVITY; DISEASE DURATION; EXHAUSTION; FEMALE; FITNESS; FUNCTIONAL STATUS; HEART RATE; HUMAN; JUVENILE DERMATOMYOSITIS; MALE; MUSCLE INJURY; OXIDATION; OXYGEN CONSUMPTION; PATIENT COMPLIANCE; PATIENT SAFETY; PHYSIOTHERAPY; PRIORITY JOURNAL; REMISSION; SEX RATIO; TREATMENT DURATION; TREATMENT OUTCOME; WORKLOAD;

AEROBIC TRAINING; CREATINE KINASE; CYCLING; FITNESS; JUVENILE DERMATOMYOSITIS; MAXIMAL OXIDATIVE CAPACITY;

ABSORPTIOMETRY, PHOTON; ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; BODY COMPOSITION; DERMATOMYOSITIS; EXERCISE; EXERCISE THERAPY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; MUSCLE STRENGTH; OXYGEN CONSUMPTION; PATIENT COMPLIANCE; RECOVERY OF FUNCTION; YOUNG ADULT;

EID: 84888432768     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2013.09.002     Document Type: Article

References (38)

1. Hicks J.E., Drinkard B., Summers R.M., Rider L.G. Decreased aerobic capacity in children with juvenile dermatomyositis. Arthritis Rheum 2002, 47:118-123.
2. Mathiesen P.R., Orngreen M.C., Vissing J., Andersen L.B., Herlin T., Nielsen S. Aerobic fitness after JDM - a long-term follow-up study. Rheumatology (Oxford) 2013, 52(2):287-295.
3. Bouchard C. Genetic determinants of regional fat distribution. Hum Reprod 1997, 12(Suppl. 1):1-5.
4. Pedersen B.K., Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 2006, 16(Suppl. 1):3-63.
5. Omori C.H., Silva C.A., Sallum A.M., et al. Exercise training in juvenile dermatomyositis. Arthritis Care Res (Hoboken) 2012, 64:1186-1194.
6. Takken T., Hemel A., Van Der Net J., Helders P.J. Aerobic fitness in children with juvenile idiopathic arthritis: a systematic review. J Rheumatol 2002, 29:2643-2647.
7. Takken T., Spermon N., Helders P.J., Prakken A.B., Van Der Net J. Aerobic exercise capacity in patients with juvenile dermatomyositis. J Rheumatol 2003, 30:1075-1080.
8. Maillard S.M., Jones R., Owens C.M., et al. Quantitative assessments of the effects of a single exercise session on muscles in juvenile dermatomyositis. Arthritis Rheum 2005, 53:558-564.
9. Olsen D.B., Orngreen M.C., Vissing J. Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy. Neurology 2005, 64:1064-1066.
10. Orngreen M.C., Olsen D.B., Vissing J. Aerobic training in patients with myotonic dystrophy type 1. Ann Neurol 2005, 57:754-757.
11. Wiesinger G.F., Quittan M., Graninger M., et al. Benefit of 6months long-term physical training in polymyositis/dermatomyositis patients. Br J Rheumatol 1998, 37:1338-1342.
12. Wiesinger G.F., Quittan M., Aringer M., et al. Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programme. Br J Rheumatol 1998, 37:196-200.
13. Alexanderson H., Stenstrom C.H., Lundberg I. Safety of a home exercise programme in patients with polymyositis and dermatomyositis: a pilot study. Rheumatology (Oxford) 1999, 38:608-611.
14. Habers G.E., Takken T. Safety and efficacy of exercise training in patients with an idiopathic inflammatory myopathy - a systematic review. Rheumatology (Oxford) 2011, 50:2113-2124.
15. Omori C., Prado D.M., Gualano B., et al. Responsiveness to exercise training in juvenile dermatomyositis: a twin case study. BMC Musculoskelet Disord 2010, 11:270.
16. Mathiesen P., Hegaard H., Herlin T., Zak M., Pedersen F., Nielsen S. Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study. Scand J Rheumatol 2012, 41(1):50-58.
17. Bohan A., Peter J.B. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975, 292:344-347.
18. Wilson R.C., Jones P.W. A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exercise. Clin Sci (Lond) 1989, 76:277-282.
19. Andersen L.B. A maximal cycle exercise protocol to predict maximal oxygen uptake. Scand J Med Sci Sports 1995, 5:143-146.
20. Rider L.G., Koziol D., Giannini E.H., et al. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken) 2010, 62:465-472.
21. Lovell D.J., Lindsley C.B., Rennebohm R.M., et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 1999, 42:2213-2219.
22. Jakicic J.M., Marcus M., Gallagher K.I., et al. Evaluation of the SenseWear Pro Armband to assess energy expenditure during exercise. Med Sci Sports Exerc 2004, 36:897-904.
23. ATS statement Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117. Jul 1.
24. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480.
25. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
26. Miller F.W., Rider L.G., Chung Y.L., et al. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) 2001, 40:1262-1273.
27. Alexanderson H., Lundberg I.E., Stenstrom C.H. Development of the myositis activities profile-validity and reliability of a self-administered questionnaire to assess activity limitations in patients with polymyositis/dermatomyositis. J Rheumatol 2002, 29:2386-2392.
28. Nielsen S., Ruperto N., Herlin T., Pedersen F.K. The Danish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001, 19:S50-S54.
29. Moriello C., Finch L., Mayo N.E. Relationship between muscle strength and functional walking capacity among people with stroke. J Rehabil Res Dev 2011, 48:267-275.
30. Feldman B.M., Rider L.G., Reed A.M., Pachman L.M. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008, 371:2201-2212.
31. Robinson A.B., Reed A.M. Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis. Nat Rev Rheumatol 2011, 7(11):664-675.
32. Wedderburn L.R., Li C.K. Paediatric idiopathic inflammatory muscle disease. Best Pract Res Clin Rheumatol 2004, 18:345-358.
33. Nagaraju K., Rider L.G., Fan C., et al. Endothelial cell activation and neovascularization are prominent in dermatomyositis. J Autoimmune Dis 2006, 3:2.
34. Takken T., Spermon N., Helders P.J., Prakken A.B., Van der N.J. Aerobic exercise capacity in patients with juvenile dermatomyositis. J Rheumatol 2003, 30:1075-1080.
35. Huemer C., Kitson H., Malleson P.N., et al. Lipodystrophy in patients with juvenile dermatomyositis - evaluation of clinical and metabolic abnormalities. J Rheumatol 2001, 28:610-615.
36. Huber A.M., Lang B., LeBlanc C.M., et al. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000, 43:541-549.
37. Ravelli A., Trail L., Ferrari C., et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res (Hoboken) 2010, 62:63-72.
38. Rider L.G., Lachenbruch P.A., Monroe J.B., et al. Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. Arthritis Rheum 2009, 60:3425-3435.